DK1126829T3 - Coatede partikler af granuleret mikrokrystallin ibuprofen - Google Patents

Coatede partikler af granuleret mikrokrystallin ibuprofen

Info

Publication number
DK1126829T3
DK1126829T3 DK99954047T DK99954047T DK1126829T3 DK 1126829 T3 DK1126829 T3 DK 1126829T3 DK 99954047 T DK99954047 T DK 99954047T DK 99954047 T DK99954047 T DK 99954047T DK 1126829 T3 DK1126829 T3 DK 1126829T3
Authority
DK
Denmark
Prior art keywords
ibuprofen
ethylcellulose
weight
relative
coated particles
Prior art date
Application number
DK99954047T
Other languages
Danish (da)
English (en)
Inventor
Jean-Marc Zuccarelli
Charles Andre Chauveau
Gilles Demichelis
Karine Jean
Original Assignee
Ethypharm Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ethypharm Sa filed Critical Ethypharm Sa
Application granted granted Critical
Publication of DK1126829T3 publication Critical patent/DK1126829T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/501—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Developing Agents For Electrophotography (AREA)
  • Glanulating (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
DK99954047T 1998-11-06 1999-11-03 Coatede partikler af granuleret mikrokrystallin ibuprofen DK1126829T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9814033A FR2785539B1 (fr) 1998-11-06 1998-11-06 Particules enrobees d'ibuprofene cristallin granule
PCT/FR1999/002682 WO2000027368A1 (fr) 1998-11-06 1999-11-03 Particules enrobees d'ibuprofene cristallin granule

Publications (1)

Publication Number Publication Date
DK1126829T3 true DK1126829T3 (da) 2004-08-09

Family

ID=9532492

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99954047T DK1126829T3 (da) 1998-11-06 1999-11-03 Coatede partikler af granuleret mikrokrystallin ibuprofen

Country Status (26)

Country Link
US (1) US6951657B1 (pl)
EP (1) EP1126829B1 (pl)
JP (1) JP3987282B2 (pl)
KR (1) KR100586059B1 (pl)
CN (1) CN1154482C (pl)
AT (1) ATE265206T1 (pl)
AU (1) AU765765B2 (pl)
BR (1) BR9915111A (pl)
CA (1) CA2349503C (pl)
CZ (1) CZ292290B6 (pl)
DE (1) DE69916876T2 (pl)
DK (1) DK1126829T3 (pl)
EA (1) EA002897B1 (pl)
ES (1) ES2219073T3 (pl)
FR (1) FR2785539B1 (pl)
HK (1) HK1039890B (pl)
HU (1) HU229936B1 (pl)
IL (1) IL142787A (pl)
MX (1) MXPA01004517A (pl)
NZ (1) NZ511479A (pl)
PL (1) PL194527B1 (pl)
PT (1) PT1126829E (pl)
SK (1) SK283944B6 (pl)
TR (1) TR200101230T2 (pl)
WO (1) WO2000027368A1 (pl)
ZA (1) ZA200103630B (pl)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2795962B1 (fr) 1999-07-08 2003-05-09 Prographarm Laboratoires Procede de fabrication de granules enrobes a gout masque et liberation immediate du principe actif
FR2824477B1 (fr) * 2001-05-09 2005-09-09 Ethypharm Lab Prod Ethiques Granules enrobes a base d'inhibiteur de l'enzyme de conversion de l'anfiotensine, leur procede de preparation et comprimes orodispersibles contenant les granules enrobes
FR2850275B1 (fr) * 2003-01-24 2005-04-08 Scherer Technologies Inc R P Capsules molles a macher contenant une substance active a gout masque
EP1800667A1 (en) 2005-12-23 2007-06-27 Losan Pharma GmbH Rapidly solubilizing ibuprofen granulate
EP2559430B1 (en) 2005-03-22 2015-06-24 Losan Pharma GmbH Solubilized Ibuprofen
WO2007012019A2 (en) * 2005-07-18 2007-01-25 Horizon Therapeutics, Inc. Medicaments containing famotidine and ibuprofen and administration of same
US8067451B2 (en) * 2006-07-18 2011-11-29 Horizon Pharma Usa, Inc. Methods and medicaments for administration of ibuprofen
US20080020040A1 (en) * 2006-07-18 2008-01-24 Horizon Therapeutics, Inc. Unit dose form for administration of ibuprofen
DE102005049001A1 (de) * 2005-10-11 2007-04-12 Basf Ag Verfahren zur Herstellung von direkttablettierbaren Ibuprofen-Formulierungen
US8067033B2 (en) 2007-11-30 2011-11-29 Horizon Pharma Usa, Inc. Stable compositions of famotidine and ibuprofen
JP2009544684A (ja) * 2006-07-27 2009-12-17 ユニヴァーシティ・オヴ・サンダーランド デンプンを含むコーティング組成物
TWI564008B (zh) * 2010-09-30 2017-01-01 鹽野義製藥股份有限公司 難溶性藥物之溶解性改善製劑
WO2014198999A1 (en) * 2013-06-13 2014-12-18 Opes Corporation Oy Matrix
US9474699B2 (en) * 2014-03-31 2016-10-25 Johnson & Johnson Consumer Inc. Compostions and methods for enhancing the topical application of a basic benefit agent
WO2016081783A1 (en) * 2014-11-19 2016-05-26 Kiromic, Llc Novel nanoparticle-based vaccine targeting cancer/testis antigens (cta) and its use in solid and hematological malignancies
CN116350618A (zh) 2017-10-26 2023-06-30 浙江越甲药业有限公司 一种稳定的含有非甾体抗炎药衍生物的药物组合物
PL3927314T3 (pl) 2019-02-22 2024-02-19 Catalent U.K. Swindon Zydis Limited Minimalizacja aglomeracji materiału powlekającego cząstki leku podczas przechowywania dla ustabilizowania czasów rozpadu produktów farmaceutycznych
PL3927322T3 (pl) 2019-02-22 2024-02-05 Catalent U.K. Swindon Zydis Limited Minimalizacja napowietrzania zawiesin podczas mieszania typu in-line
CA3129404A1 (en) 2019-02-22 2020-08-27 Catalent U.K. Swindon Zydis Limited Preserving functionally-coated api particles produced by solventless mixing processes in aqueous suspension
GB2597577B (en) 2019-02-22 2023-09-20 Catalent Uk Swindon Zydis Ltd Minimizing agglomeration, aeration, and preserving the coating of pharmaceutical compositions comprising ibuprofen
EP4188324A1 (en) 2020-07-31 2023-06-07 Catalent U.K. Swindon Zydis Limited Pharmaceutical compositions comprising coated api
WO2025237808A1 (en) * 2024-05-14 2025-11-20 Zambon S.P.A. Orodispersible pharmaceutical compositions comprising an amino acid salt of ibuprofen

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4308251A (en) * 1980-01-11 1981-12-29 Boots Pharmaceuticals, Inc. Controlled release formulations of orally-active medicaments
US4588612A (en) * 1985-04-24 1986-05-13 Scm Corporation Pretreatment in encapsulation process
GB8519310D0 (en) * 1985-07-31 1985-09-04 Zyma Sa Granular active substances
US4835186A (en) 1987-06-15 1989-05-30 American Home Products Corporation Spray dried ibuprofen
US4835187A (en) * 1987-06-15 1989-05-30 American Home Products Corporation Spray dried ibuprofen
US5084278A (en) * 1989-06-02 1992-01-28 Nortec Development Associates, Inc. Taste-masked pharmaceutical compositions
NZ234587A (en) * 1989-08-04 1991-11-26 Mcneil Ppc Inc A chewable pharmaceutical tablet of compressed coated granules
IT1241417B (it) * 1990-03-06 1994-01-14 Vectorpharma Int Composizioni terapeutiche a rilascio controllato di farmaci supportatisu polimeri reticolati e rivestiti con film polimerici,e loro processodi preparazione
CA2076983A1 (en) * 1990-04-11 1991-10-12 Robert Wu-Wei Shen Taste masking of ibuprofen by fluid bed coating
FR2679451B1 (fr) * 1991-07-22 1994-09-09 Prographarm Laboratoires Comprime multiparticulaire a delitement rapide.
US5191114A (en) * 1991-10-09 1993-03-02 Sage Pharmaceuticals, Inc. Process for enhancing the flow characteristics of ibuprofen
ZA945944B (en) * 1993-08-13 1996-02-08 Eurand America Inc Procedure for encapsulating nsaids
US5567439A (en) * 1994-06-14 1996-10-22 Fuisz Technologies Ltd. Delivery of controlled-release systems(s)

Also Published As

Publication number Publication date
FR2785539B1 (fr) 2004-04-09
TR200101230T2 (tr) 2001-10-22
JP2002529399A (ja) 2002-09-10
CA2349503A1 (fr) 2000-05-18
EA002897B1 (ru) 2002-10-31
CN1328450A (zh) 2001-12-26
CA2349503C (fr) 2010-07-13
AU765765B2 (en) 2003-09-25
US6951657B1 (en) 2005-10-04
AU1050800A (en) 2000-05-29
BR9915111A (pt) 2001-11-27
EA200100491A1 (ru) 2001-12-24
JP3987282B2 (ja) 2007-10-03
HUP0104394A3 (en) 2002-12-28
ES2219073T3 (es) 2004-11-16
ZA200103630B (en) 2002-05-06
HK1039890A1 (en) 2002-05-17
CZ292290B6 (cs) 2003-08-13
HUP0104394A2 (hu) 2002-03-28
CZ20011434A3 (cs) 2001-09-12
DE69916876T2 (de) 2005-03-31
HK1039890B (zh) 2005-01-07
ATE265206T1 (de) 2004-05-15
NZ511479A (en) 2003-02-28
EP1126829B1 (fr) 2004-04-28
SK283944B6 (sk) 2004-05-04
DE69916876D1 (de) 2004-06-03
KR100586059B1 (ko) 2006-06-07
HU229936B1 (en) 2015-01-28
EP1126829A1 (fr) 2001-08-29
MXPA01004517A (es) 2003-06-09
PL347549A1 (en) 2002-04-08
PT1126829E (pt) 2004-08-31
FR2785539A1 (fr) 2000-05-12
SK5662001A3 (en) 2001-11-06
KR20010090830A (ko) 2001-10-19
CN1154482C (zh) 2004-06-23
PL194527B1 (pl) 2007-06-29
IL142787A (en) 2007-06-03
WO2000027368A1 (fr) 2000-05-18

Similar Documents

Publication Publication Date Title
DK1126829T3 (da) Coatede partikler af granuleret mikrokrystallin ibuprofen
DE69529050D1 (de) Orale dosierungsformen mit pulverschicht
ES2125099T3 (es) Composiciones que comprenden nanoparticulas de un antiinflamatorio no estereoideo.
AR015919A1 (es) Formas de dosificacion de liberacion sostenida de sertralina, sales de sertralina ,composicion farmaceutica, procedimiento depreparacion y su uso en terapias.
AU6517496A (en) Oral pharmaceutical composition containing antimicrobial actives and sustained release pantoprazole
DK0841904T3 (da) Orale farmaceutiske præparater med forsinket frigivelse af reversible protonpumpeinhibitorer
ATE334663T1 (de) Arzneimittelzusammensetzung mit verzögerter wirkstoffabgabe
ATE239454T1 (de) Orale morphinzubereitung in teilchenform
GR3030084T3 (en) Sprayable film forming system releasing active substances for use on plants
NO304638B1 (no) Peroralt anvendelige legemiddelformer for behandling av sentrale dopaminmangeltilstander
DK0868912T3 (da) Anvendelse af redispergerbare polymerpulvere eller polymergranulater til coating af farmaceutiske eller agrokemiske applikationsformer
MX9204637A (es) Nuevos derivados de pirazina y procedimiento para su preparacion.
DE69622739D1 (de) Pharmazeutische zubereitung mit schneller freisetzung
JPS5714589A (en) Benzothiazine derivative, its preparation and drug composition
ES2132122T3 (es) Procedimiento para la preparacion de composiciones polimericas.
DK1178780T3 (da) Multipartikelformige formuleringer til kontrolleret frigivelse af selektiv serotoningenoptagelseshæmmer
NO950950L (no) Farmasöytisk preparat
DE60105381D1 (de) Valproat-Formulierungen mit gesteuerter Freigabe
ATE154238T1 (de) Arzneimittel verzögerter wirkstoffabgabe
JPS57128627A (en) Analgesic and antiphlogistic composition
JPS5296745A (en) Aqueous agent for immunity control
JPS5521733A (en) Production of antibiotic y-12278 and carcinostatic preparation containing the same as the effective ingredient
WO1996015798A3 (de) Verwendung von bio-assimilierbaren borverbindungen zur bekämpfung subviröser krankheitserreger
ATE534371T1 (de) Pharmazeutische zubereitungen und verfahren zu deren herstellung
AP2003002905A0 (en) Sertraline salts and sustained-release dosage forms of sertraline.